[Corrections] Corrections

van Schaik IN, Bril V, van Geloven N, et al. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol 2018; 17: 35 –46—“J Gamez Carbonell” in the Path study group should have been listed as “J Gamez”. This correction has been made to the online version as of Dec 15, 2017, and to the printed Article.

Source: Lancet Neurology - December 16, 2017 Category: Neurology Tags: Corrections Source Type: research